cyclohexamide chx (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
99
Structured Review
MedChemExpress
cyclohexamide chx
Cyclohexamide Chx, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 2594 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chx/Cycloheximide/pm42071007-117-7-9
Average 99 stars, based on 2594 article reviews
Cyclohexamide Chx, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 2594 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chx/Cycloheximide/pm42071007-117-7-9
Average 99 stars, based on 2594 article reviews
cyclohexamide chx - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Blocking Assay:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Inhibition:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Incubation:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Translocation Assay:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Stability:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Western Blot:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Oligomer Restriction:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Mouse Assay:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Chloramphenicol Acetyltransferase Assay:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Binding Assay:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Clone Assay:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( DNA Extraction:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Amplification:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Polymerase Chain Reaction:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Plasmid Preparation:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Extraction:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( CRISPR:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Functional Assay:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Transfection:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( Control:Article Title: The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy Article Snippet: owed to adhere overnight. Cells were then pre-treated with SaB (100 μM) or PBS for 24 h to ensure adequate drug-protein engagement prior to protein synthesis inhibition. Subsequently, 10 μg/mL of CHX ( |